Chronic widespread pain, including fibromyalgia: A pathway for care developed by the British Pain Society

British Journal of Anaesthesia

Volumn 112, Issue 1, 2014, Pages 16-24

  Lee, J ^a,b   Ellis, B ^c   Price, C ^d   Baranowski, A P ^b,e  

^a Cayman Islands Hospital   (Cayman Islands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^e NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

chronic pain; fibromyalgia

Indexed keywords

BUPRENORPHINE; FENTANYL; HYDROCODONE; METHADONE; MORPHINE; OXYCODONE; PETHIDINE; TRAMADOL;

ANALGESIA; ARTICLE; CHRONIC PAIN; CHRONIC WIDESPREAD PAIN; CLINICAL PATHWAY; COGNITIVE THERAPY; EXPECTATION; FIBROMYALGIA; FOLLOW UP; HEALTH CARE; HUMAN; MEDICAL SOCIETY; MEDICAL SPECIALIST; PATIENT INFORMATION; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR;

EID: 84890520039     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet351     Document Type: Article

References (44)

1. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006; 10: 287-333
2. Reid KJ, Harker J, BalaMM,et al. Epidemiologyof chronicnon-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin 2011; 27: 449-62
3. Smith BH, Torrance N. Epidemiology of neuropathic pain and its impact on quality of life. Curr Pain Headache Rep 2012; 16: 191-8
4. Gustorff B, Dorner T, Likar R, et al. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiol Scand 2008; 52: 132-6
5. Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain 2000; 84: 95-103
6. Right Care. NHS Atlas of Variation in Healthcare, 2011; 51-54. Available from http://www.rightcare.nhs.uk/index.php/nhs-atlas/atlasdownloads/(accessed January 2013)
7. Koes BW, van Tulder M, Lin CW, Macedo LG, McAuley J, Maher C. An updatedoverviewof clinical guidelines for themanagement ofnonspecific lowback pain in primary care. Eur Spine J 2010; 19: 2075-94
8. The Map of Medicine and the British Pain Society. Chronic Widespread Pain, Including Fibromyalgia. England View. London: Map of Medicine, 2013
9. Lee J, GuptaS, Price C, BaranowskiAP. Lowbackandradicular pain:a pathway for care developed by the British Pain Society. Br J Anaesth 2013; 111: 112-20
10. SmithBH, Lee J, Price C, BaranowskiAP.Neuropathic pain: a pathway for caredevelopedby theBritishPain Society. Br JAnaesth2013;111: 73-9
11. The Map of Medicine and the British Pain Society. Initial Assessment and Early Management of Pain. London: Map of Medicine, 2012
12. The Map of Medicine and the British Pain Society. Pelvic Pain. England View. London: Map of Medicine, 2013
13. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-72
14. Croft P, Rigby AS, Boswell R, Schollum J, Silman A. The prevalence of chronic widespread pain in the general population. J Rheumatol 1993; 20: 710-3
15. Papageorgiou AC, Silman AJ, Macfarlane GJ. Chronic widespread pain in the population: a seven year follow up study. Ann Rheum Dis 2002; 61: 1071-4
16. Arnold LM. Strategies for managing fibromyalgia. Am J Med 2009; 122(12 Suppl.): S31-43
17. National Institute for Health and Clinical Excellence (NICE). Treating depression in adults with a long term physical health problem. Clinical guideline 90. London, 2009
18. National Institute for Health and Clinical Excellence (NICE). Management of long term sickness for incapacity for work. Public Health Guideline 19. London, 2009
19. Goldenberg DL, Burckhardt C, Crofford L.Management of fibromyalgia syndrome. J Am Med Assoc 2004; 292: 2388-95
20. White KP, Nielson WR, Harth M, Ostbye T, Speechley M. Does the label 'fibromyalgia' alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis Rheum 2002; 47: 260-5
21. Hughes G, Martinez C, Myon E, Ta?̈eb C, Wessely S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 2006; 54: 177-83
22. Rossy LA, BuckelewSP, Dorr N, et al. A metaanalysis of fibromyalgia treatment interventions. Ann Behav Med 1999; 21: 180-91
23. Williams DA. Psychological and behavioural therapies in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 2003; 17: 649-65
24. Busch AJ, Barber KA, Overend TJ, Peloso PM, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev 2007; 4: CD003786
25. SmithSM, Soubhi H, Fortin M,HudonC,O'DowdT. Managingpatients with multimorbidity: systematic review of interventions in primary care and community settings. Br Med J 2012; 345: e5205, doi: 10.1136/bmj.e5205
26. Katon WJ,Lin EHB,Von Korff M, etal.Collaborativecareforpatientswith depression and chronic illnesses. N Engl J Med 2010; 363: 2611-20
27. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia andmeasurement of symptomseverity. Arthritis Care Res (Hoboken) 2010; 62: 600-10
28. Kato K, Sullivan PF, Evenga°rd B, Pedersen NL. Importance of genetic influences on chronic widespread pain. Arthritis Rheum 2006; 54: 1682-6
29. Gracely RH, Ambrose KR. Neuroimaging of fibromyalgia. Best Pract Res Clin Rheumatol 2011; 25: 271-84
30. Lillefjell M, Krokstad S, Espnes GA. Prediction of function in daily life following multidisciplinary rehabilitation for individuals with chronic musculoskeletal pain; a prospective study. BMC Musculoskelet Disord 2007; 8: 65
31. Hoving JL, deVet HC, TwiskJW, et al. Prognostic factors for neck pain in general practice. Pain 2004; 110: 639-45
32. Mourao AF, Blyth FM, Branco JC. Generalised musculoskeletal pain syndromes. Best Pract Res Clin Rheumatol 2010; 24: 829-40
33. Nicassio PM, Radojevic V,Weisman MH, et al.Acomparisonofbehavioral and educational interventions for fibromyalgia. J Rheumatol 1997; 24: 2000-7
34. Alamo M, Moral RR, Perula de Torres LA. Evaluation of a patientcenteredapproachingeneralizedmusculoskeletal chronicpain/fibromyalgia patients inprimary care. Patient Educ Couns 2002; 48: 23-31
35. Glennon P. Fibromyalgia syndrome: management in primary care. Reports on the Rheumatic Diseases. Arthritis Research UK. Chesterfield, 2010; 6
36. HäuserW,Wolfe F, Tö lle T, Uçeyler N, Sommer C. The role of antidepressants in themanagement of fibromyalgia syndrome:a systematic review and meta-analysis. CNS Drugs 2012; 26: 297-307
37. Crofford LJ, Mease PJ, Simpson SL, et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 2008; 136: 419-31
38. Passik SD,Weinreb HJ. Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids. Adv Ther 2000; 17: 70-83
39. Morgan D. Senate probes painkiller makers, allied groups. Reuters. Washington, May 9, 2012
40. Ballantyne JC. Chronic opioid therapy and its utility in different populations. Pain 2012; 153: 2303-4
41. Crofford LJ. Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nat Rev Rheumatol 2010; 6: 191-7
42. British Pain Society. Opioids for Persistent Pain: Good Practice. London, 2010
43. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic non cancer pain. J Pain 2009; 10: 113-30
44. Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle A.Arandomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 1994; 21: 714-20